EMEA-002133-PIP01-17-M03

Table of contents

Key facts

Invented name
Fetcroja
Active substance
Cefiderocol
Therapeutic area
Infectious diseases
Decision number
P/0441/2022
PIP number
EMEA-002133-PIP01-17-M03
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of infections due to aerobic Gram-negative bacteria
Route(s) of administration
Intravenous use
Contact for public enquiries
Shionogi Limited

E-mail: shionogiclintrials-admin@shionogi.co.jp
Tel. +44 (0)20 3534 200

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating